Show simple item record

dc.contributor.advisorKarim, Eshaba
dc.contributor.authorJony, Md. Nazmul Islam
dc.date.accessioned2023-04-06T08:19:58Z
dc.date.available2023-04-06T08:19:58Z
dc.date.copyright2021
dc.date.issued2021-02
dc.identifier.otherID: 16146041
dc.identifier.urihttp://hdl.handle.net/10361/18100
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 29-30).
dc.description.abstractThe Food and Drug Administration (FDA) is responsible for protecting and ensuring the safety of the American public health by approving and monitoring drug products. They do so with strict supervision. This study was done to find out any correlation between drug products approved by FDA and the nature of disease. Since chronic diseases are growing in global prevalence and directly threatening the health of the world population, this study attempted to identify if the most frequently approved drug products are for the treatment of such diseases. Data was collected from the official FDA website and analyzed to find out how frequently products containing each active pharmaceutical ingredient were approved. The ATC codes for the APIs were enlisted. This was used to identify their therapeutic classes. Most of the therapeutic classes suggested that the FDA has indeed approved more drug products for the treatment of chronic diseases than acute diseases.en_US
dc.description.statementofresponsibilityMd. Nazmul Islam Jony
dc.format.extent30 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectFDAen_US
dc.subjectChronic Diseasesen_US
dc.subjectGlobal Prevalenceen_US
dc.subjectUnique API Listen_US
dc.subjectATC codesen_US
dc.subjectTherapeutic Classesen_US
dc.subject.lcshUnited States. Food and Drug Administration.
dc.titleA study on drug product approval by the FDA from 1930 to 2019en_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record